Effects of Methylnaltrexone on Ticagrelor-Induced Antiplatelet Effects in Coronary Artery Disease Patients Treated With Morphine.

Author: AngiolilloDominick J, BassTheodore A, BeenLatonya, FazGabriel, FranchiFrancesco, HuJenny, KuretiMegha, ParkYongwhi, PinedaAndres M, Rivas RiosJose, RolliniFabiana, SofferDaniel, SuryadevaraSiva, YaranovDmitry, ZenniMartin M

Paper Details 
Original Abstract of the Article :
OBJECTIVES: The aim of this study was to assess if intravenous methylnaltrexone can counteract the effects of morphine on the pharmacokinetic (PK) and pharmacodynamic (PD) profiles of ticagrelor. BACKGROUND: Morphine delays the onset of action of oral P2Y METHODS: In this prospective, randomized, ...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://doi.org/10.1016/j.jcin.2019.05.028

データ提供:米国国立医学図書館(NLM)

Methylnaltrexone: Can It Counteract Morphine's Effects on Ticagrelor?

This research explores the potential of methylnaltrexone, a peripheral opioid receptor antagonist, to counteract the effects of morphine on ticagrelor, an antiplatelet medication. The researchers conducted a prospective, randomized, double-blind, crossover study to assess the impact of methylnaltrexone on the pharmacokinetic and pharmacodynamic profiles of ticagrelor in patients with coronary artery disease who were receiving morphine.

Methylnaltrexone's Minimal Impact

The study found that intravenous administration of methylnaltrexone had only marginal effects on the plasma levels of ticagrelor and its active metabolite. While there were slight increases in ticagrelor levels, methylnaltrexone did not significantly affect the platelet reactivity, as measured by the VerifyNow P2Y12 assay. This is like adding a small amount of water to a large desert pool – a minimal impact on the overall environment.

Navigating Drug Interactions with Caution

This research emphasizes the need for careful consideration of drug interactions, especially in patients receiving multiple medications. While methylnaltrexone showed minimal impact on ticagrelor's pharmacokinetic and pharmacodynamic profiles, further research is needed to fully understand its effects in various clinical scenarios. It's like navigating a desert road with a slightly faulty compass – it's important to be aware of potential limitations and navigate cautiously.

Dr.Camel's Conclusion

This research is like a camel caravan carefully traversing a desert landscape, assessing potential risks and obstacles along the way. It highlights the complexity of drug interactions and the need for cautious monitoring, especially when combining medications that might affect platelet function. The study offers valuable insights into the interaction between methylnaltrexone and ticagrelor, providing a map for navigating this complex terrain.

Date :
  1. Date Completed 2020-09-01
  2. Date Revised 2020-09-01
Further Info :

Pubmed ID

31377269

DOI: Digital Object Identifier

10.1016/j.jcin.2019.05.028

Related Literature

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.